Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts rolling review of mRNA COVID-19 vaccine by Moderna Biotech Spain, S.L. 16 November 2020NewsHumanCOVID-19MedicinesVaccines Emer Cooke takes office as head of EMA 16 November 2020NewsCorporateAntimicrobial resistanceInnovation EMA publishes safety monitoring plan and guidance on risk management planning for COVID-19 vaccines 13 November 2020NewsHumanCOVID-19Pharmacovigilance Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2020 13 November 2020NewsHumanMedicines Ulipristal acetate for uterine fibroids: EMA recommends restricting use 13 November 2020NewsHumanReferrals Nitrosamines: EMA aligns recommendations for sartans with those for other medicines 13 November 2020NewsHumanReferrals Message from EMA’s outgoing Executive Director, Guido Rasi 13 November 2020NewsCorporateCOVID-19 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-5 November 2020 6 November 2020NewsVeterinaryMedicinesVaccines International regulators and WHO join forces to address COVID-19 challenges 6 November 2020NewsHumanCOVID-19 Regulatory information – 1.7% and 1.6% increase of pharmacovigilance fees from 1 November 2020 4 November 2020NewsHumanFeesPharmacovigilance 1 … 73 74 75 76 77 Page 77 of 380 78 79 80 81 … 380
EMA starts rolling review of mRNA COVID-19 vaccine by Moderna Biotech Spain, S.L. 16 November 2020NewsHumanCOVID-19MedicinesVaccines
Emer Cooke takes office as head of EMA 16 November 2020NewsCorporateAntimicrobial resistanceInnovation
EMA publishes safety monitoring plan and guidance on risk management planning for COVID-19 vaccines 13 November 2020NewsHumanCOVID-19Pharmacovigilance
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2020 13 November 2020NewsHumanMedicines
Ulipristal acetate for uterine fibroids: EMA recommends restricting use 13 November 2020NewsHumanReferrals
Nitrosamines: EMA aligns recommendations for sartans with those for other medicines 13 November 2020NewsHumanReferrals
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-5 November 2020 6 November 2020NewsVeterinaryMedicinesVaccines
International regulators and WHO join forces to address COVID-19 challenges 6 November 2020NewsHumanCOVID-19
Regulatory information – 1.7% and 1.6% increase of pharmacovigilance fees from 1 November 2020 4 November 2020NewsHumanFeesPharmacovigilance